Authors: Poldermans, D Boersma, E Bax, JJ Thomson, IR Paelinck, B van de Ven, LLM Scheffer, MG Trocino, G Vigna, C Baars, HF van Urk, H Roelandt, JRTC

Citation: D. Poldermans et al., Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery, EUR HEART J, 22(15), 2001, pp. 1353-1358

Authors: Boersma, E Poldermans, D Bax, JJ Steyerberg, EW Thomson, IR Banga, JD van de Ven, LLM van Urk, H Roelandt, JRTC

Citation: E. Boersma et al., Predictors of cardiac events after major vascular surgery - Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy, J AM MED A, 285(14), 2001, pp. 1865-1873

Authors: Vanmolkot, FHM de Hoon, JNJM van de Ven, LLM Van Bortel, LMAB

Citation: Fhm. Vanmolkot et al., Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide, J HUM HYPER, 13(8), 1999, pp. 559-563

Authors: Poldermans, D Boersma, E Bax, JJ Thomson, IR van de Ven, LLM Blankensteijn, JD Baars, HF Yo, TI Trocino, G Vigna, C Roelandt, JRTC van Urk, H

Citation: D. Poldermans et al., The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery, N ENG J MED, 341(24), 1999, pp. 1789-1794